Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue
7M 6.13M 6.26M 7.34M 6.35M 6.02M 5.48M 6.16M 4.78M 4.25M 3.75M 4.08M 22.51K 15.69K 14.12K n/a n/a n/a n/a
Cost of Revenue
1.94M 3.75M 2.15M 4.13M 1.99M 1.97M 1.65M 1.86M 1.22M 1.21M 990K 1.02M 17.9K 35.88K 5.66K n/a n/a n/a n/a
Gross Profit
5.06M 2.38M 4.12M 3.2M 4.36M 4.05M 3.83M 4.29M 3.56M 3.04M 2.76M 3.06M 4.62K -20.18K 8.47K n/a n/a n/a n/a
Operating Income
-7.44M -9.04M -10.39M -11.39M -5.95M -6.74M -7.51M -5.14M -6.59M -5.88M -4.31M -5.76M -6.41M -5.33M -3.87M -4.13M -5M -5.3M -2.33M
Interest Income
977K 1.04M 1.09M 1.15M 1.44M 1.46M 1.41M 1.3M 1.01M 277K 107K 95.89K 94.3K 112.11K 55.15K 11.29K 21.24K 247.00 n/a
Pretax Income
-6.72M -24.07M -9.33M -21.95M -2.41M -5.33M -6.18M -3.86M -5.65M -5.66M -4.21M -5.62M -6.35M -4.71M -4.04M -4.17M -4.98M -5.31M -2.45M
Net Income
-6.7M -23.93M -9.16M -22.41M -491K -5.25M -6.38M -2.81M -5M -5.27M -3.94M -3.29M -6.35M -4.71M -4.04M -4.17M -4.98M -5.31M -2.45M
Selling & General & Admin
10.65M 9.92M 12.73M 11.49M 9.44M 9.93M 10.43M 8.65M 9.02M 8.6M 6.72M 8.16M 6.12M 5.04M 3.47M 3.17M 2.17M 1.27M 1.54M
Research & Development
1.84M 1.51M 1.77M 3.1M 867K 859K 918K 777K 1.13M 319K 351K 664.9K 288.45K 270.67K 413.13K 838.22K 2.7M 3.91M 630.07K
Other Expenses
n/a 52K 84K -115K 2.19M n/a -1K 1K -5K 1K -1K 49.38K 600.00 -22.2K n/a 1.14K 1.96K 122.85K 5.5K
Operating Expenses
12.5M 11.43M 14.5M 14.59M 10.31M 10.79M 11.35M 9.43M 10.15M 8.92M 7.08M 8.83M 6.41M 5.31M 3.88M 4.13M 5M 5.3M 2.33M
Interest Expense
n/a n/a n/a n/a 64K 62K 50K 1K 1.01M n/a 107K 3.46K n/a 6.05K n/a 81.00 n/a n/a 651.00
Selling & Marketing Expenses
3.89M 3.92M 4.11M 4.31M 3.33M 3.08M 3.42M 3.41M 3.73M n/a n/a n/a n/a n/a n/a 84.97K 59.56K 67.83K 49.55K
Cost & Expenses
14.44M 15.17M 16.65M 18.73M 12.29M 12.76M 12.99M 11.29M 11.37M 10.13M 8.06M 9.85M 6.43M 5.34M 3.89M 4.13M 5M 5.3M 2.33M
Income Tax Expense
-27K -143K -166K 459K -1.92M -77K 208K -1.05M -657K -382K -278K -2.33M 32.37K -534.05K 219.63K 57.14K 2.74K 5.69K 121.96K
Shares Outstanding (Basic)
979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.9M 979.9M 978.49M 978.49M 942.2M 890.25M 890.25M 550.54M 214.83M 118.34M
Shares Outstanding (Diluted)
979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.95M 979.9M 979.9M 978.49M 978.49M 973.66M 890.25M 890.25M 550.54M 214.83M 118.34M
EPS (Basic)
-0.01 -0.02 -0.01 -0.02 -0.00 -0.01 -0.01 -0.00 -0.01 -0.01 -0.00 -0.00 -0.01 -0.01 -0.00 -0.00 -0.01 -0.02 -0.02
EPS (Diluted)
-0.01 -0.02 -0.01 -0.02 -0.00 -0.01 -0.01 -0.00 -0.01 -0.01 -0.00 -0.00 -0.01 -0.00 -0.00 -0.00 -0.01 -0.02 -0.02
EBITDA
-4.7M -22.1M -7.39M -20.08M -751K -3.79M -4.76M -2.63M -4.5M -4.83M -3.4M -4.79M -6.3M -5.23M -3.77M -4.05M -4.86M -5.19M -2.29M
EBIT
-6.72M -24.07M -9.33M -21.95M -2.35M -5.26M -6.13M -2.59M -5.65M -5.66M -4.21M -5.62M -6.41M -5.33M -3.87M -4.17M -4.98M -5.31M -2.45M
Depreciation & Amortization
2.03M 1.98M 1.93M 1.87M 1.6M 1.47M 1.36M 1.23M 1.15M 830K 819K 828.22K 107.18K 100.55K 103.65K 119.67K 123.6K 122.85K 163.9K